The SMART-LV Pilot Study
Left Ventricular Systolic Dysfunction
About this trial
This is an interventional device feasibility trial for Left Ventricular Systolic Dysfunction
Eligibility Criteria
Inclusion Criteria: Provision of signed and dated informed consent form. Stated willingness to comply with all study procedures and availability for the duration of the study Exclusion Criteria: Patients who have undergone a prior echocardiogram. Patients with a prior diagnosis of left ventricular dysfunction, based on a documented low ejection fraction (EF) in the medical record. Patients with an intermediate predicted probability of low EF (10 to 80%) Patients with a prior diagnosis of heart failure as determined by International Classification of Diseases-10 diagnosis code for heart failure. Research opt-out patients
Sites / Locations
- Yale New Haven HospitalRecruiting
Arms of the Study
Arm 1
Experimental
AI-ECG
A novel AI-ECG model developed at the Cardiovascular Data Science (CarDS) lab will be used as Software as Medical Device (SaMD) on ECG images for detection of LVSD.The AI-ECG model will be used on all participants undergoing a 12-lead ECG.